Covid-19 Vaccinations


Facility Partners,


As many of you are already aware, on August 12, 2021, the FDA and CDC approved a third dose of Pfizer-BioNTech and Moderna’s COVID-19 vaccines for certain immunocompromised individuals. If you have residents who fit the “immunocompromised” category and are currently eligible for a third dose, please reach out to your Account Manager to discuss how you can obtain the recommended third dose through our Maintenance Program.


Shortly after the authorization of the third dose for immunocompromised individuals, the Biden administration announced that booster shots will be available the week of September 20th for non-immunocompromised individuals. Please note that no official authorization for these boosters has been issued by the FDA at this time. The FDA is planning to meet September 17th to review the evidence and we will communicate further information if and when an official recommendation is issued


Thank you for your continued partnership and we will communicate with you as soon as we have more information.



TJ Griffin                                                                 Lane Sieman

Chief Pharmacy Officer, PharMerica                 Senior Vice President, Client Services, PharMerica

Sales Inquiry?

Contact us today to start a new partnership in delivering superior care.